GlassScriptPhysician profile
Lori A Marshall
NPI 1720077118
$1,744.90
in general payments reported to CMS, 2019-2025
27 companies · $539 in 2025
The $539 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $80.81 · 2022: $418 · 2023: $261 · 2024: $264 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.52 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $269.10 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $216.49 | 2019-2023 | |
| Astellas Pharma US INC | $152.68 | 2023-2024 | Veozah, Myrbetriq |
| Medtronic, INC. | $133.56 | 2022 | |
| Organon LLC | $132.57 | 2024-2025 | Jada System |
| Millicent US INC | $112.71 | 2024-2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $107.12 | 2022-2025 | |
| Aspira Women'S Health INC | $99.13 | 2022 | |
| Therapeuticsmd, INC. | $76.28 | 2019 | |
| Optumhealth Care Solutions, LLC | $67.82 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Ferring Pharmaceuticals INC. | $65.24 | 2023 | Menopur |
| Amgen INC. | $36.47 | 2019-2020 | |
| Myovant Sciences INC. | $28.83 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.83 | 2019-2020 | |
| Exeltis, USA INC. | $19.94 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Z-Medica, LLC | $19.92 | 2020 | |
| Hologic Sales and Service, LLC | $19.89 | 2022 | |
| Merck Sharp & Dohme LLC | $19.34 | 2025 | Gardasil 9 |
| Pfizer INC. | $19.27 | 2023 | |
| Dexcom, INC. | $18.83 | 2025 | Dexcom G6 Transmitter |
| Hydrofera LLC | $17.33 | 2025 | Hydrofera Blue |
| Mylan Pharmaceuticals INC. | $17.18 | 2019 | |
| Smith+Nephew, INC. | $16.22 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Ascend Therapeutics US, LLC | $15.38 | 2019 | |
| Avion Pharmaceuticals | $14.36 | 2019 | |
| Allergan, INC. | $12.83 | 2019 | |
| Channel Medsystems, INC. | $9.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.